TRAWS PHARMA INC
TRAW·68232V884·US·Common Stock·Healthcare - Biotechnology-Activist
TRAW (TRAWS PHARMA INC) is held by 15 institutional investors as of Q1 2026. Largest holders: ADAGE CAPITAL PARTNERS GP, L.L.C. ($1.3M), GEODE CAPITAL MANAGEMENT, LLC ($141,100), VANGUARD CAPITAL MANAGEMENT LLC ($101,003). Net institutional sentiment: Mixed.
15
Holders
Avg rating(2 Elite)
$1.8M
Total Value
59% (21)
Fund Consensus
10 buying - 7 selling
Who's Trading
ActivistPAPerceptive Advisors LLC6.1%May 15, 2026
ActivistSMSquadron Master Fund LP6.4%May 15, 2026
ActivistOAORBIMED ADVISORS LLC11.9%May 5, 2026
InsiderOLORBIMED ADVISORS LLCBuy $998KApr 16, 2026
ActivistIKIkarian Capital, LLC10.0%Feb 17, 2026
ActivistADAdage Capital Management, L.P.9.1%Feb 12, 2026
ActivistAYAyrton Capital LLC4.3%Feb 11, 2026
ActivistCJChernett Jorey6.8%Jan 16, 2026
13F: Insider & Congress:
Showing 1-20 of 21
1 / 2
Continue exploring
Other Healthcare stocks held by institutions
LLYELI LILLY & CO
413 holders · $666.6B
UNHUNITEDHEALTH GROUP INC413 holders · $186.3B
JNJJOHNSON & JOHNSON394 holders · $391.3B
DHRDANAHER CORP DEL392 holders · $97B
ISRGINTUITIVE SURGICAL INC391 holders · $123.5B
TMOTHERMO FISHER SCIENTIFIC INC391 holders · $147B
BSXBOSTON SCIENTIFIC CORP389 holders · $76.8B
MRKMERCK & CO INC385 holders · $208.9B
ABBVABBVIE INC381 holders · $254.9B
ABTABBOTT LABORATORIES380 holders · $129.1B
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer